EP Patent

EP3435980B1 — Physiologically balanced injectable formulations of fosnetupitant

Assigned to Helsinn Healthcare SA · Expires 2019-11-13 · 7y expired

What this patent protects

Patent listed against fosnetupitant-chloride-hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
EP3435980B1
Jurisdiction
EP
Classification
—
Expires
2019-11-13
Drug substance claim
No
Drug product claim
No
Assignee
Helsinn Healthcare SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.